Today, February 6th, the Minsk Scientific and Practical Centre for Surgery, Transplantology and Haematology performed its first ...

An extra set of eyes on radiology scans, double-checking for signs of prostate cancer. A green light telling surgeons when it ...

THREE quarters of cancer patients will beat the disease under plans to boost NHS care, Wes Streeting has pledged. He aims to have 75 per cent of those diagnosed from 2035 onwards either cured or ...

Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & ...

At present, just 60% live well five years after diagnosis but the Government wants to push this to 75%.

By Dr. Priyom Bose, Ph.D. Drawing on 52 studies, this review challenges assumptions about athletic advantage between cis- and transgender athletes, while highlighting major evidence gaps in elite and ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).

WholeFoods Magazine's Natural Choice Awards (NCAs) recognize the brands and products that independent natural products ...

NHS cancer care should be transformed over the next decade, health chiefs said ...

The University of Texas MD Anderson Cancer Center is pleased to announce the national launch of an innovative new science exhibition, showcasing the groundbreaking research, technologies and promising ...

Robin “Shyne” Edwards is building more than a brand; she’s cultivating a community rooted in access, visibility, and empowerment. As the founder of Noir, Edwards is reshaping how technology, ...